Evidence map›Paper›PMID 36345417›Full record

ArticleNuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment2022

Depth dose measurements in water for

Daria Boscolo, Daria Kostyleva, Christoph Schuy, Uli Weber, Emma Haettner, Sivaji Purushothaman, Peter Dendooven, Timo Dickel, Vasyl Drozd, Bernhard Franczack and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Production and separation of positron emitters for hadron therapy at FRS-Cave M.Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms · 2023
    Article
  4. Emerging technologies for cancer therapy using accelerated particles.Progress in particle and nuclear physics · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 4 countries.

Daria BoscoloGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Daria KostylevaGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Christoph SchuyGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Uli WeberGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Emma HaettnerGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Sivaji PurushothamanGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Peter DendoovenUniversity Medical Center Groningen, Groningen, Netherlands.
Timo DickelGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Vasyl DrozdGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Bernhard FranczackGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Hans GeisselGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Christine HornungGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Felix HorstGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Erika KazantsevaGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Natalia Kuzminchuk-FeuersteinGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Giulio LovattiLudwig-Maximilians-Universität München, Munich, Germany.
Ivan MukhaGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Chiara NociforoGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Stephane PietriGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Marco PintoLudwig-Maximilians-Universität München, Munich, Germany.
Claire-Anne ReidelGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Heidi RoeschGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Olga SokolGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Yoshiki K TanakaRIKEN High Energy Nuclear Physics Laboratory, Wako, Japan.
Helmut WeickGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Jianwei ZhaoGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Christoph ScheidenbergerGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Katia ParodiLudwig-Maximilians-Universität München, Munich, Germany.
Marco DuranteGSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
GSI Helmholtz Centre for Heavy Ion Research · DELudwig-Maximilians-Universität München · DEHigh Energy Accelerator Research Organization · JPUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

European Research Council 883425
6 · The paper itself

Abstract

Owing to the favorable depth-dose distribution and the radiobiological properties of heavy ion radiation, ion beam therapy shows an improved success/toxicity ratio compared to conventional radiotherapy. The sharp dose gradients and very high doses in the Bragg peak region, which represent the larger physical advantage of ion beam therapy, make it also extremely sensitive to range uncertainties. The use of

Indexed as

Carbon ionsIon beam therapyRadioactive ion beamsRange monitoring

Identifiers

PMID36345417
PMCPMC7613790
OpenAlexW4295960003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.